Clarivate (NYSE:CLVT) Releases FY 2025 Earnings Guidance

Clarivate (NYSE:CLVT) issued an update on its FY 2025 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of 0.600-0.700 for the period, compared to the consensus estimate of 0.730. The company issued revenue guidance of $2.3 billion-$2.4 billion, compared to the consensus revenue estimate of $2.6 billion.

Clarivate Trading Down 1.5 %

NYSE:CLVT opened at $4.83 on Wednesday. The company has a debt-to-equity ratio of 0.84, a current ratio of 0.88 and a quick ratio of 0.88. The stock has a 50-day simple moving average of $5.15 and a two-hundred day simple moving average of $5.82. Clarivate has a 52-week low of $4.25 and a 52-week high of $9.07.

Clarivate declared that its board has authorized a share repurchase program on Monday, December 16th that allows the company to repurchase $500.00 million in shares. This repurchase authorization allows the company to reacquire up to 12.8% of its shares through open market purchases. Shares repurchase programs are typically an indication that the company’s leadership believes its stock is undervalued.

Analyst Ratings Changes

CLVT has been the subject of a number of recent analyst reports. William Blair lowered Clarivate from an “outperform” rating to a “market perform” rating in a research note on Wednesday, November 6th. Barclays dropped their price target on Clarivate from $5.00 to $4.00 and set an “underweight” rating for the company in a research note on Thursday, November 7th. Finally, Royal Bank of Canada dropped their price target on Clarivate from $7.00 to $6.00 and set a “sector perform” rating for the company in a research note on Thursday, November 7th. One research analyst has rated the stock with a sell rating, three have given a hold rating and two have given a buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $7.10.

Insider Buying and Selling at Clarivate

In other Clarivate news, Director Michael J. Angelakis purchased 765,000 shares of Clarivate stock in a transaction dated Friday, November 22nd. The shares were purchased at an average cost of $5.19 per share, for a total transaction of $3,970,350.00. Following the completion of the acquisition, the director now owns 3,465,000 shares in the company, valued at $17,983,350. This represents a 28.33 % increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available at this hyperlink. Company insiders own 23.14% of the company’s stock.

Clarivate Company Profile

Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications.